Skip to content

Clinical effect of Shenmai injection on perioperative myocardial protection of coronary artery bypass surgery under off-pump bypass

Clinical effect of Shenmai injection on perioperative myocardial protection of coronary artery bypass surgery under off-pump bypass

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086936
Enrollment
Unknown
Registered
2024-07-15
Start date
2024-07-29
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

group s:Dilute 0.6mL/kg of Shenmai Injection to 250mL using 5% glucose injection, and administer intravenously at a rate of 150ml/h at the beginning of the surgery.
group c:Start intravenous infusion of 150 mL of 5% glucose injection at a rate of 150 ml/h during surgical skin cutting

Sponsors

Dongyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: a. Age range from 45 to 75 years old; b. ASA classification II-IV, grade; c. Body mass index 18.5-30kg/m ².

Exclusion criteria

Exclusion criteria: a. Patients with allergies to Shenmai injection; b. Patients who need to undergo coronary artery bypass surgery under extracorporeal circulation during surgery; c. Pregnant and lactating women; d. Severe left ventricular dysfunction (EF<35%), e. Preoperative respiratory failure (PaO2<60mmHg), f. Severe uncontrolled hypertension or hypotension

Design outcomes

Primary

MeasureTime frame
Creatine kinase isoenzyme;

Secondary

MeasureTime frame
Mean arterial pressure;heart rate;Troponin;BNP;Heart index;Left ventricular ejection fraction;Blood lactate;Interleukin-6;Superoxide dismutase;Extubation time;ICU stay time;Length of hospital stay;Cardiovascular adverse events at 30 days postoperatively;Procalcitonin;

Countries

China

Contacts

Public ContactLiu Ying

Dongyang People's Hospital

501946185@qq.com+86 136 2589 8532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026